We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -0.65% | 308.00 | 307.00 | 309.00 | 315.00 | 306.00 | 312.00 | 45,426 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
(Adds pricing of the offer, updates share price)
By Adria Calatayud
London-listed shares in Hutchison China MediTech Ltd. (HCM.LN) fell Monday after the company said shareholder CK Hutchison Holdings Ltd. (0001.HK) plans to sell a 1.3% stake.
This would reduce CK Hutchison's stake in the company to 49.9% from 51.1%, allowing it to deconsolidate the investment from its financial statements, Hutchison China MediTech said.
The offering price was set at $17.65 for each American depositary share, Hutchison China MediTech said. Each ADS represents five ordinary shares, the company said.
The China-focused pharmaceutical company, which is listed in the U.K. and the U.S., said the Hong Kong-based conglomerate has no intention of selling additional shares in Hutchison China MediTech for the foreseeable future upon completion of the current offering.
Hutchison China MediTech's London-listed shares at 1320 GMT were down 5% at 285 pence.
Write to Adria Calatayud at adria.calatayudvaello@dowjones.com
(END) Dow Jones Newswires
September 30, 2019 09:53 ET (13:53 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Hutchmed (china) Chart |
1 Month Hutchmed (china) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions